NIH 2021 R44 CA |
BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. Silberstein, David S. / Biomimetix Jv, LLC |
|
NIH 2020 R44 CA |
BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. Silberstein, David S. / Biomimetix Jv, LLC |
|
NIH 2018 R44 CA |
BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. Silberstein, David S. / Biomimetix Jv, LLC |
|